Ophthalmic Devices Market Overview:
Global Ophthalmic Devices Market was valued at $46,029 million in 2015, and is expected to reach $62,113 million by 2022, supported by a CAGR of 4.3% during the forecast period 2014 to 2022. Ophthalmology is a branch of medical sciences that deals with the structure, function, and various eye diseases. The ophthalmic devices are medical equipment designed for diagnosis, surgical, and vision correction purposes. These devices gain increased importance and adoption due to high prevalence of various ophthalmic diseases such as glaucoma, cataract, and other vision related issues. The report analyzes the ophthalmic devices market based on product function and geography.
Global Ophthalmic Devices Market: Segmentation
According to the AMR analysis, the contact lenses market is expected to grow at a fastest rate in the ophthalmic vision care devices market. This is primarily attributed to a shift in the preference of the users from spectacles toward easy to use contact lenses. The aging population constitutes increase in number of vision related problems, expected to drive the market for contact lenses in the developed as well as the developing nations.
High adoption of digital devices worldwide
The increase in rapid urbanization is parallel to the adoption of digital devices such as computers, smartphones, tablets, laptops, television, game consoles, and e-reader. Continuous long hours spent in front of the screen results into various eye related issues such as eye strain, itchy eyes, headaches, blurred vision, or neck pain. The screen of these devices emits artificial blue light which can be harmful and result into AMD. Currently, the use of these devices is on an increase across all age groups.
Digital Devices Usage Statistics, by Age Group
Usage and Impact of Digital Devices on the Vision
The key players profiled in the report include Novartis AG, Carl Zeiss Meditec AG, Essilor International S.A., HAAG-Streit Holding AG, Johnson & Johnson, Nidek Co., Ltd., Topcon Corporation, Valeant Pharmaceuticals International, Inc., Hoya Corporation, and Ziemer Ophthalmic Systems AG. The other players operating in the industry include Sonomed Escalon, Gulden Ophthalmics, FCI Ophthalmics, Glaukos Corporation, and STAAR Surgical.
The study provides an in-depth analysis of the global ophthalmic devices market along with the current trends and future estimations to elucidate the imminent investment pockets.
The report provides quantitative analyses of the industry for the period of 2014‐2022 to enable stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the global ophthalmic devices market helps understand the adoption of ophthalmic devices for surgical, diagnostic, and vision care applications.
Competitive intelligence highlights the business practices followed by leading market players across various geographies.
Ophthalmic Devices Market Key Segments
The global ophthalmic devices market is segmented based on product function and geography.
By Product function
- Ophthalmic Surgical Devices
- Refractive Error Surgical Devices
- Excimers and Femtosecond Lasers
- Glaucoma Surgical Devices
- Implants and Stents
- Glaucoma Drainage
- Glaucoma Laser Devices
- Cataract Surgery Devices
- Intraocular Lenses
- Phacoemulsification Systems
- Vitreoretinal Surgical Devices
- Vitrectomy Machines & Vitrectomy Packs
- Photocoagulation Lasers
- Illumination Devices
- Refractive Error Surgical Devices
- Ophthalmic Diagnostic Devices
- Corneal Topography Systems
- Retinal Ultrasound Systems
- Fundus Camera
- Optical Coherence Tomography Systems
- Slit Lamps
- Ophthalmic Vision Care Devices
- Contact Lenses
- Spectacle Lenses
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- South Africa
- Saudi Arabia
- Rest of LAMEA